Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-081205
Filing Date
2024-09-24
Accepted
2024-09-24 08:29:32
Documents
1
Period of Report
2024-09-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-67043.html 4  
1 PRIMARY DOCUMENT marketforms-67043.xml 4 3881
  Complete submission text file 0001213900-24-081205.txt   5313
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUCELL CORPORATION 56 EVERGREEN DR. PORTLAND ME 04103
Business Address
Rosgen Steven T. (Reporting) CIK: 0001729885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 241317602